Format

Send to

Choose Destination
J Biopharm Stat. 2013;23(5):1042-53. doi: 10.1080/10543406.2013.813523.

A note on partial covariate-adjustment and design considerations in noninferiority trials when patient-level data are not available.

Author information

1
U.S. Food and Drug Administration (US FDA), Division of Biometrics IV, Office of Biometrics/CDER/OTS/FDA, Silver Spring, Maryland 20993, USA. lei.nie@fda.hhs.gov

Abstract

The traditional fixed margin approach to evaluating an experimental treatment through an active-controlled noninferiority trial is simple and straightforward. However, its utility relies heavily on the constancy assumption of the experimental data. The recently developed covariate-adjustment method permits more flexibility and improved discriminatory capacity compared to the fixed margin approach. However, one major limitation of this covariate-adjustment methodology is its adherence on the patient-level data, which may not be accessible to investigators in practice. In this article, under some assumptions, we examine the feasibility of a partial covariate-adjustment approach based on data typically available from journal publications or other public data when the patient-level data are unavailable. We illustrate the usefulness of this approach through two real examples. We also provide design considerations on the efficiency of the partial covariate-adjustment approach.

PMID:
23957514
DOI:
10.1080/10543406.2013.813523
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center